2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Oral and Injectable ADT in US Prostate Cancer Patients"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jason Hafron

642 views

June 13, 2024

Comments 1

ASCO® 2024 Insights: "Landscape Analysis & Oncologic Outcomes in Adv…

2024 ASCO® Annual Meeting Insights Hub

T. Stewart

11 views

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

606 views

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

379 views

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

268 views

ASCO® 2024 Summary: "Prostate Cancer Highlights"

2024 ASCO® Annual Meeting Insights Hub

N. Reizine, K. Tawagi

575 views

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

547 views

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.8K views

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel + Abiraterone vs…

2024 ASCO® Annual Meeting Insights Hub

C. Kyriakopoulos

348 views

ASCO® 2024 Insights: "A Clinical-Genetic ctDNA-Based Prognostic Mode…

2024 ASCO® Annual Meeting Insights Hub

S. Halabi

161 views

ASCO® 2024 Insights: "Systemic Treatments in Favorable and Very Favo…

2024 ASCO® Annual Meeting Insights Hub

M. Zarba

245 views

ASCO® 2024 Insights: "MAST Study - Metformin in Reducing Progression…

2024 ASCO® Annual Meeting Insights Hub

N. Fleshner

184 views

ASCO® 2024 Insights: "TRANSFORMER Trial - Blood-Based Markers of Dif…

2024 ASCO® Annual Meeting Insights Hub

E. Antonarakis

167 views

ASCO® 2024 Insights: "Impact of Exposure on Outcomes With Enfortumab…

2024 ASCO® Annual Meeting Insights Hub

D. Petrylak

169 views

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - …

2024 ASCO® Annual Meeting Insights Hub

C. Paller

173 views

ASCO® 2024 Summary: "Advances in RCC and Urothelial Carcinoma - Key …

2024 ASCO® Annual Meeting Insights Hub

C. Porta

96 views

ASCO® 2024 Summary: "Expert Panel Discussion on the Real World Evide…

ecancer

F. Schlürmann, B. Hadaschik, K. Fizazi

193 views

ASCO® 2024 Summary: "Expert Panel Discussion on Best Practices in HR…

ecancer

M. Schostak, A. Wyatt, C. Ryan, E. Antonarakis

182 views

ASCO® 2024 Insights: "KEYNOTE-426 Trial - Biomarker Analysis of Pemb…

2024 ASCO® Annual Meeting Insights Hub

B. Rini

104 views

ASCO® 2024 Insights: "Organ Preserving and Reconstructive Surgery in…

2024 ASCO® Annual Meeting Insights Hub

A. Burnett

158 views

ASCO® 2024 Insights: "CYCLONE 2 Study - Abemaciclib + Abiraterone in…

2024 ASCO® Annual Meeting Insights Hub

T. Todenhöfer

57 views

ASCO® 2024 Insights: "Study EV-103 - Neoadjuvant Enfortumab Vedotin …

2024 ASCO® Annual Meeting Insights Hub

N. Mar

138 views

ASCO® 2024 Insights: "MANCAN2 Trial - Self-Help Cognitive Behavioura…

2024 ASCO® Annual Meeting Insights Hub

S. Crabb

134 views

ASCO® 2024 Insights: "PSMAfore - HRQoL and Pain in Taxane-Naïve mCRP…

ecancer

K. Fizazi

79 views

ASCO® 2024 Insights: "EMBARK Post Hoc Analysis of Sexual Activity PR…

2024 ASCO® Annual Meeting Insights Hub

S. Freedland

146 views

ASCO® 2024 Insights: "Harnessing the Immune System in RCC - Current …

2024 ASCO® Annual Meeting Insights Hub

D. Braun

198 views

ASCO® 2024 Insights: "EMBARK Study - Impact of Treatment Suspension …

2024 ASCO® Annual Meeting Insights Hub

S. Freedland

162 views

ASCO® 2024 Insights: "CHAARTED2 Trial - Cabazitaxel With Abiraterone…

ecancer

C. Kyriakopoulos

45 views

ASCO® 2024 Insights: "Belzutifan for Advanced Renal Cell Carcinoma"

2024 ASCO® Annual Meeting Insights Hub

E. Jonasch

215 views

Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Sett…

2024 ASCO® Annual Meeting Insights Hub

V. Murthy

201 views

ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA Assessm…

2024 ASCO® Annual Meeting Insights Hub

T. Powles

185 views

ASCO® 2024 Insights: "ARV-766, a PROTAC Androgen Receptor Degrader, …

2024 ASCO® Annual Meeting Insights Hub

D. Petrylak

109 views

ASCO® 2024 Insights: "SURE-01/02 Study - Perioperative Sacituzumab G…

ecancer

A. Cigliola

46 views

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

642 views

ASCO® 2024 Insights: "1L Systemic Therapy Following Adjuvant IO in R…

2024 ASCO® Annual Meeting Insights Hub

T. El Zarif

245 views

ASCO® 2024 Insights: "Lenvatinib + Pembro vs. Sunitinib in aRCC - Pa…

2024 ASCO® Annual Meeting Insights Hub

V. Grünwald

122 views

ASCO® 2024 Insights: "Clinical Utility of Transcriptomic Signatures …

2024 ASCO® Annual Meeting Insights Hub

Y. Chen

137 views

ASCO® 2024 Insights: "CORE-001 Study - Final Results of Cretostimoge…

2024 ASCO® Annual Meeting Insights Hub

R. Li

29 views

ASCO® 2024 Insights: "ABBV-706 Study - Targeted ADC for Advanced Sol…

2024 ASCO® Annual Meeting Insights Hub

B. Garmezy

56 views

ASCO® 2024 Insights: "CA-62 - A New Biomarker for the Detection of E…

2024 ASCO® Annual Meeting Insights Hub

E. Klinski

30 views

ASCO® 2024 Insights: "AURA Trial Survival Data - Avelumab as Neoadju…

2024 ASCO® Annual Meeting Insights Hub

J. Blanc

173 views

ASCO® 2024 Insights: "HERCULES Trial - Pembro + Platinum-Based Chemo…

2024 ASCO® Annual Meeting Insights Hub

F. Maluf

96 views

ASCO® 2024 Insights: "KIM-1 Biomarker Analysis in IMmotion010 - Adju…

2024 ASCO® Annual Meeting Insights Hub

L. Albiges

65 views

ASCO® 2024 Insights: "CheckMate 67T Trial - Safety & PROs of Subcuta…

2024 ASCO® Annual Meeting Insights Hub

M. Bourlon

97 views

ASCO® 2024 Insights: "LITESPARK-013 Study Subgroup Analysis - Belzut…

2024 ASCO® Annual Meeting Insights Hub

M. Atkins

102 views

Login

Login

Join VuMedi